<bill session="116" type="hr" number="242" updated="2022-11-01T18:02:32Z">
  <state datetime="2019-03-18">REFERRED</state>
  <status>
    <introduced datetime="2019-03-18"/>
  </status>
  <introduced datetime="2019-03-18"/>
  <titles>
    <title type="display">Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.</title>
    <title type="official" as="introduced">Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.</title>
  </titles>
  <sponsor bioguide_id="B001251"/>
  <cosponsors>
    <cosponsor bioguide_id="B001257" joined="2019-03-18"/>
    <cosponsor bioguide_id="B000490" joined="2019-10-17"/>
    <cosponsor bioguide_id="F000461" joined="2019-05-01"/>
    <cosponsor bioguide_id="L000590" joined="2019-09-17"/>
    <cosponsor bioguide_id="N000191" joined="2020-01-27"/>
    <cosponsor bioguide_id="Y000062" joined="2019-10-28"/>
  </cosponsors>
  <actions>
    <action datetime="2019-03-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-03-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-03-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional tributes"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health care quality"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medical research"/>
    <term name="Prescription drugs"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2019-09-26T21:57:09Z" status="Introduced in House">This resolution applauds the growth in research and development into new therapies for rare diseases and recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.</summary>
</bill>
